Matthew C. Kiernan

The University of Sydney

Papers

1

Total Citations

20

H-Index

1

About

Matthew C. Kiernan is a leading figure in neuromuscular medicine and clinical neurophysiology, with his research primarily focused on amyotrophic lateral sclerosis (ALS), peripheral neuropathy, and the application of advanced electromyography (EMG) techniques. He has made transformative contributions to understanding motor neuron degeneration and developing diagnostic criteria for ALS, including the influential Awaji criteria. His work has also advanced the use of nerve excitability testing to assess axonal function in health and disease. With over 50,000 citations, Kiernan’s research has profoundly shaped clinical practice and therapeutic development. Notably, he led the Consensus for Experimental Design in Electromyography (CEDE) project, which established standardized protocols for using EMG to estimate muscle force—a critical tool for biomechanics, rehabilitation, and robotics. As a clinician-scientist and editor-in-chief of the *Journal of Neurology, Neurosurgery & Psychiatry*, Kiernan’s work bridges fundamental neuroscience and patient care, making him a pivotal figure in neurology.

Research Focus

Key Achievements

1
H-Index
1
Papers
20
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Consensus for experimental design in electromyography (CEDE) project: Application of EMG to estimate muscle force
20 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: The University of Sydney

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago